Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: The Ets transcription factor ESE-1 mediates induction of the COX-2 gene
Nội dung xem thử
Mô tả chi tiết
The Ets transcription factor ESE-1 mediates induction
of the COX-2 gene by LPS in monocytes
Franck T. Grall, Wolf C. Prall, Wanjiang Wei, Xuesong Gu, Je-Yoel Cho, Bob K. Choy,
Luiz F. Zerbini, Mehmet S. Inan, Steven R. Goldring, Ellen M. Gravallese, Mary B. Goldring,
Peter Oettgen and Towia A. Libermann
New England Baptist Bone and Joint Institute and BIDMC Genomics Center, Beth Israel Deaconess Medical Center and Harvard Medical
School, Boston, USA
Cyclooxygenase (COX) is an enzyme that converts
arachidonic acid into the prostaglandin H2. This product is the critical point of the synthetic pathway of
numerous members of the prostaglandin family. COX
exists as two major isoforms derived from two separate
genes: COX-1 and COX-2. COX-1 is constitutively
expressed, whereas COX-2 expression is inducible.
Pro-inflammatory substances are some of the major
activators of COX-2. Examples include interleukin
(IL)-1 [1], tumor necrosis factor (TNF)-a [2], and bacterial lipopolysaccharide (LPS) [3]. A third isoform
COX-3 has also been reported [4].
The mechanisms leading to COX-2 expression
involve various combinations of different transcription
factors, depending on the cell type and stimulus. The
members of the C ⁄EBP family have been identified as
Keywords
COX-2; ESE-1; Ets; gene expression; LPS
Correspondence
T. A. Libermann, New England Baptist Bone
& Joint Institute, Department of Medicine,
Beth Israel Deaconess Medical Center,
Harvard Institutes of Medicine, 4 Blackfan
Circle, Boston, MA 02115, USA
Fax: +1 617 975 5299
Tel: +1 617 667 3393
E-mail: [email protected]
(Received 21 July 2004, revised 19 January
2005, accepted 2 February 2005)
doi:10.1111/j.1742-4658.2005.04592.x
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX-2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We
present here a novel role for the Ets transcription factor ESE-1 in regulating the COX-2 gene in response to endotoxin and other pro-inflammatory
stimuli. We report that the induction of COX-2 expression by lipopolysaccharide (LPS) and pro-inflammatory cytokines correlates with ESE-1
induction in monocyte ⁄ macrophages. ESE-1, in turn, binds to several E26
transformation specific (Ets) sites on the COX-2 promoter. In vitro analysis
demonstrates that ESE-1 binds to and activates the COX-2 promoter to
levels comparable to LPS-mediated induction. Moreover, we provide
results showing that the induction of COX-2 by LPS may require ESE-1,
as the mutation of the Ets sites in the COX-2 promoter or overexpression
of a dominant-negative form of ESE-1 inhibits LPS-mediated COX-2
induction. The effect of ESE-1 on the COX-2 promoter is further enhanced
by cooperation with other transcription factors such as nuclear factor-jB
and nuclear factor of activated T cells. Neutralization of COX-2 is the goal
of many anti-inflammatory drugs. As an activator of COX-2 induction,
ESE-1 may become a target for such therapeutics as well. Together with
our previous reports of the role of ESE-1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro-inflammatory cytokines
in vascular and connective tissue cells, these results establish ESE-1 as an
important player in the regulation of inflammation.
Abbreviations
Ad, Adenovirus; ChIP, chromatin immunoprecipitation; CMV, cytomegalovirus; COX, cyclooxygenase; CRE, cAMP responsive element;
ESE, epithelium specific Ets factor; Ets, E26 transformation specific; GAPDH, glyceraldehydes-3-phosphate dehydrogenase; HRP,
horseradish peroxidase; ICAM, intercellular adhesion molecule; IL, interleukin; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide;
MMP, matrix metalloproteinase; NFAT, nuclear factor of activated T cells; NF-jB, nuclear factor-jB; TNF, tumor necrosis factor.
1676 FEBS Journal 272 (2005) 1676–1687 ª 2005 FEBS